Moderna News and Biotech Innovation Updates
Moderna Inc. (NASDAQ: MRNA) is a biotechnology company specializing in messenger RNA (mRNA) therapeutics and vaccines. Best known for its COVID-19 vaccine, Moderna leverages mRNA technology to develop treatments for infectious diseases, cancer, autoimmune conditions, and rare genetic disorders. Its modular platform enables rapid drug development and scalable manufacturing, positioning the company at the forefront of biotech innovation. Headquartered in Cambridge, Massachusetts, Moderna continues to expand its clinical pipeline and forge strategic partnerships with governments and research institutions worldwide. The company's long-term mission is to transform medicine by unlocking the potential of mRNA to treat and prevent a wide range of diseases.
63.49
1.69
2.73 %
Real-time price
15:44
USD
Daily range
60.90
67.36
67.36
Weekly range
49.69
62.30
62.30
What triggered Moderna shares' latest price surge
Moderna Inc (MRNA) is currently trading at $63.75 after a daily gain of 3.16%. The stock remains well above its 20-day ($49.08), 50-day ($49.96), and 200-day ($39.02) moving averages, signaling a ...
Why is Moderna stock up today?
Moderna Inc (MRNA) is trading at $58.58, up $3.18 or 5.74% for the day, positioning itself significantly above the 20-day ($48.28), 50-day ($49.73), and 200-day ($38.83) moving averages. This ...
FDA boost lifts Moderna shares: Can MRNA extend rally?
Moderna shares moved higher after the FDA released briefing documents related to the company's mFlu influenza vaccine, which investors interpreted as a positive signal for the potential approval ...
Buying pressure lifts Moderna stock higher in today's trading
Moderna Inc. (MRNA) is trading decisively above its key short-term, medium-term, and long-term moving averages, with the price ($55.76) above the MA-20 ($47.91), MA-50 ($49.60), and MA-200 ...
What is behind Moderna stock's recent gain in value today
Moderna Inc. (MRNA) is trading at $50.67, up 2.07% today. The stock sits above its 20-day ($47.77), 50-day ($49.54), and 200-day ($38.42) moving averages, highlighting persistent bullish trends ...
Moderna eyes breakout as investors focus on its next growth drivers
Moderna shares continue to recover after a challenging period between 2023 and 2025. The key question now is whether the stock can break out of its current consolidation range in the near ...
Why is Moderna stock down today?
Moderna Inc. (MRNA) is trading at $46.42, below the 20-day ($48.17) and 50-day ($49.61) moving averages, reflecting persistent short- and medium-term selling pressure, while remaining well above ...
Moderna edges higher to $47.60 after MHRA approves mRNA-4194 Lynch syndrome trial, moderna_tx says
Moderna received authorization from the UK’s Medicines and Healthcare products Regulatory Agency for its Phase 1/2 clinical study evaluating mRNA-4194.The investigational mRNA-based vaccine is ...
Moderna edges higher to $47.60 as Oxford cancer vaccine trial gains UK authorization, moderna_tx announces
Moderna said it has received Medicines and Healthcare products Regulatory Agency (MHRA) authorization in the UK for a Phase 1/2 study of mRNA-4194, its investigational cancer vaccine for Lynch ...
Why is Moderna stock up today?
Moderna Inc. (MRNA) is currently trading near $47.23, below both the 20-day ($48.56) and 50-day ($49.93) moving averages, but well above the 200-day average at $37.67. This setup points to ...
Buying pressure lifts Moderna stock higher in today's trading
Moderna Inc (MRNA) is currently trading at $48.67, registering a daily gain of 2.31%. The stock sits just above its 20-day moving average ($48.55) and remains below the 50-day moving average ...
Why is Moderna stock down today?
Moderna Inc (MRNA) is currently trading at $46.53, down 2.27% on the day. The asset remains below its 20-day ($48.45) and 50-day ($50.40) moving averages, indicating continued short- and ...
What is behind Moderna stock's recent gain in value today
Moderna Inc (MRNA) is trading at $48.17 after gaining 2.42% on the day. The stock currently sits just below its 20-day and 50-day simple moving averages ($48.43 and $50.51, respectively), but ...
Selling pressure pushes Moderna stock lower in today's trading
Moderna Inc. (MRNA) is currently trading at $46.96, down 2.42% for the day. The price remains below its MA-20 ($48.99) and MA-50 ($50.93), yet comfortably above its MA-200 ($36.85), indicating ...
Moderna shares jump as stock buying pressure builds
Moderna Inc (MRNA) remains under pressure, with the current price of $46.99 up 2.78% on the day. The asset is trading well below both the 20-day ($49.36) and 50-day ($51.07) simple moving ...
Moderna stock holds steady amid regulatory review of mRNA-1010 in US, EU, Canada, Australia
Moderna Inc. (MRNA) is trading at $48.60, down 0.40% for the day, and is currently positioned below its key short- and medium-term moving averages, while staying above ...
Moderna shares dip amid rising selling pressure
Moderna Inc (MRNA) is trading at $49.06, down 3.29% on the day and moving below the 20-day and 50-day moving averages. The share price remains well above the 200-day moving average, reflecting ...
What is behind Moderna stock's recent drop in value today
Moderna Inc (MRNA) is currently trading at $50.89, marking a daily decline of 2.32%. The stock remains just below the 20-day simple moving average at $51.69 but is positioned above both the 50-day ...
Moderna stock consolidates as short-term sellers dominate near $53.35 resistance
Moderna Inc (MRNA) is trading at $48.32, down 0.92% for the day. The stock remains below its MA-20 ($52.12) and MA-50 ($49.03) but stays well above the MA-200 ($33.66), ...
EMA panel recommendation for mCOMBRIAX approval sees Moderna stock fall 7.49%
Moderna announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization in the European Union ...
What is behind Moderna stock's recent drop in value today
Moderna Inc. (MRNA) is trading at $50.94, reflecting a daily decline of $2.63 or 4.91%. The stock is positioned below the 20-day moving average ($53.31), above the 50-day moving average ($48.43), ...
